Preventive treatment of priapism in sickle cell disease with oral and self-administered intracavernous injection of etilefrine
Authors:
- Dora BachirDBDora Bachir
- Ketty LeeKLKetty Lee
- Frédéric GalacterosFGFrédéric Galacteros
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- High Flow Priapism Associated with Sickle Cell DiseaseJournal of Urology, 1995
- Association of Sickle Cell Disease, Priapism, Exchange Transfusion and Neurological Events: Aspen SyndromeJournal of Urology, 1993
- The usefulness of ethylephrine (Efortil-R) in the treatment of priapism and intraoperative penile erectionsInternational Urology and Nephrology, 1992
- Priapism Associated With the Sickle Cell Hemoglobinopathies: Prevalence, Natural History and SequelaeJournal of Urology, 1991
- Priapism as a Complication of Sickle Cell DiseaseJournal of Urology, 1991
- Diagnostic and therapeutic technology assessment. Vasoactive intracavernous pharmacotherapy for impotence: papaverine and phentolamine1990
- Physiology of Erection and Pharmacological Management of ImpotenceJournal of Urology, 1987
- ABOUT PHARMACOLOGICALLY INDUCED PROLONGED ERECTIONThe Lancet, 1985
- INTRACAVERNOUS INJECTION OF PAPAVERINE FOR ERECTILE FAILUREThe Lancet, 1982
- Megalophallus in Sickle Cell DiseaseJournal of Urology, 1977